AKT1 and melanoma: This study found that melatonin combined with thapsigargin or tunicamycin directly influenced cell death of B16F10 melanoma cells via the PI3K/Akt/mTOR pathway, suggesting that melatonin combined with ER stress could be a new therapeutic strategy for effective melanoma treatment.